Jeffrey N Simmons bought $478K of Elanco Animal Health Incorporated (ELAN)
Executed Dec 11 2025, disclosed Dec 15 2025, 4 days later.
Over the 21 trading sessions from the disclosed entry session (Dec 15 2025), the stock returned +13.7% (delay-adjusted); from the execution session (Dec 11 2025), +11.9%. Derived: entry at the session's open, exit at the close 20 sessions later.
Jeffrey N Simmons (PRESIDENT, CEO AND DIRECTOR) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in Elanco Animal Health Incorporated (ELAN). Across 1 priced purchase filing, the average 21-session return was +11.9% from execution and +13.7% from disclosure (delay-adjusted; derived). The largest single filing was $478K of ELAN (22,000 sh × $21.75, as filed), executed Dec 11 2025.
Healthcare · Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm anim…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→